TBH Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$246.00 |
| 52 Week High | US$320.00 |
| 52 Week Low | US$232.00 |
| Beta | 1.09 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -18.54% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 557.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| TBH | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | -0.4% |
| 1Y | -18.5% | -3.6% | 4.2% |
Return vs Industry: TBH underperformed the German Medical Equipment industry which returned -2.7% over the past year.
Return vs Market: TBH underperformed the German Market which returned 4.7% over the past year.
Price Volatility
| TBH volatility | |
|---|---|
| TBH Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: TBH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TBH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 14,000 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| TBH fundamental statistics | |
|---|---|
| Market cap | €9.71b |
| Earnings (TTM) | €396.85m |
| Revenue (TTM) | €2.69b |
24.5x
P/E Ratio3.6x
P/S RatioIs TBH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TBH income statement (TTM) | |
|---|---|
| Revenue | US$2.79b |
| Cost of Revenue | US$1.27b |
| Gross Profit | US$1.53b |
| Other Expenses | US$1.12b |
| Earnings | US$412.27m |
Last Reported Earnings
Sep 25, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.79 |
| Gross Margin | 54.67% |
| Net Profit Margin | 14.75% |
| Debt/Equity Ratio | 43.8% |
How did TBH perform over the long term?
See historical performance and comparison